Skip to main content
. 2020 Dec 18;12(12):3821. doi: 10.3390/cancers12123821

Figure 4.

Figure 4

Loss of GRP78 is associated with worse clinical outcome. (A) Kaplan–Meier plots of disease-free survival for low and high staining of IGFBP-3 in GRP78-negative tumours (n = 26; p = 0.134). (B) Representative images of GRP78 and IGFBP-3 IHC staining. (C) The overall survival of breast cancer patients was analysed in the METABRIC database in GRP78-negative tumours based on IGFBP-3 gene expression profile (n = 83; p = 0.003). Statistically significant differences were determined by two-sided log-rank test.